This content is current only at the time of printing. This document was printed on 26 May 2020. A current copy is located at https://apvma.gov.au/node/56506
You are here
2,4-D chemical review consultation
This consultation closed on 31 January 2020.
After considering the scientific data and risk assessment outcomes, the APVMA proposes the following regulatory actions:
a. Vary under section 34A(1) of the Code, the conditions of the approval of the 2,4-D active constituents specified in Attachment 1 of the Special Gazette containing the Proposed Regulatory Decisions;
b. Vary under section 34A(1) of the Code, the relevant particulars of the approved 2,4-D chemical product labels specified in Attachment 2 of the Special Gazette; in the manner indicated in Attachment 4 of the Special Gazette; and then
c. Affirm under section 34(1) of the Code, the 2,4-D active constituent approvals shown in Attachment 1 of the Special Gazette and AFFIRM the label approvals as well as their associated product registrations as shown in Attachment 2 of the Special Gazette; but
d. Cancel under section 34AA(1) of the Code, the registration of products and approval of associated labels in group 22b containing 80 g/L 2,4-D as DMA/DEA salt, 336 g/L Mecoprop and 40 g/L Dicamba as shown in Attachment 3 of the Special Gazette; and
e. If the APVMA makes the above decisions, it proposes to:
i. Determine that section 81(3) is to apply to earlier approved labels as shown in Attachment 2 of the Special Gazette from the date of its final regulatory decision for a period of one year for the continued supply of registered chemical products bearing the earlier approved label; and
ii. Issue instructions under section 45A(2)(b)(ii) for possessing, having custody of, using and supplying the cancelled products and associated labels for a period of one year from the date of its final regulatory decision.
Submissions from the public are invited
This proposed regulatory decisions report:
- outlines the APVMA reconsideration process
- summarises the technical assessments
- outlines the proposed regulatory action to be taken in relation to the continued approval and registration of 2,4-D in Australia.
The APVMA invites written comments on this report. All comments on this report will be assessed by the APVMA prior to finalisation of the reconsideration and publication of the final regulatory decision.
Preparing your comments for submission
When making your comments:
- clearly identify the issue and clearly state your point of view
- give reasons for your comments, supporting them, if possible, with relevant scientific information and indicating the source of the information you have used
- suggest to the APVMA any alternative risk management solutions you may have.
Please structure your comments in point form, referring each point to the relevant section in the report.
Electronic submissions are preferred, and submissions with an email address will be acknowledged electronically.
When making a submission please include:
- contact name
- company or group name (if relevant)
- postal address
- email address
- the date the submission was sent to the APVMA.
The closing date for submissions is 31 January 2020.
Note that all submissions received are subject to legislation, including the Freedom of Information Act 1982, the Privacy Act 1988 and the Agvet Codes. In providing your submission to the APVMA, you agree to the APVMA publicly disclosing your submission in whole or summary form.
Submissions can be sent to: